Stock analysts at StockNews.com assumed coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research note issued to investors on Tuesday. The firm set a “hold” rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Stock Performance
NASDAQ:SRNE opened at $0.01 on Tuesday. The stock has a fifty day moving average price of $0.01 and a two-hundred day moving average price of $0.01. Sorrento Therapeutics has a 1 year low of $0.00 and a 1 year high of $0.25.
About Sorrento Therapeutics
Further Reading
- Five stocks we like better than Sorrento Therapeutics
- Compound Interest and Why It Matters When Investing
- Why the Buy-and-Hold Strategy May Be Best for Most Investors
- Investing in Construction Stocks
- Eli Lilly’s Path to the Next Trillion Market Capitalization
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Mobileye Global: CEO Makes $10 Million Bet on Future Strength
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.